RanD was founded in 1999. The name itself comes from the acronym R&D (Research and Development), which directly reflects RanD's core business: the development of technologically innovative systems based on extracorporeal circulatory technologies. Over the years, the company has developed systems designed primarily for surgical oncology.
Official partner site: RanD